Oscar Health, Inc. (OSCR)
Oscar Health, Inc. (OSCR) Advances But Underperforms Market: Key Facts
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $12.85, representing a +0.16% change from its previous close.
Oscar Health, Inc. (OSCR) Laps the Stock Market: Here's Why
Oscar Health, Inc. (OSCR) reachead $13.45 at the closing of the latest trading day, reflecting a +1.74% change compared to its last close.
Here's how Oscar Health CEO Mark Bertolini wants to fix the health insurance system
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, discusses potential solutions to some of the problems in the health insurance industry and why he believes the individual insurance market is the solution for Americans.
Oscar Health CEO on fixing the health insurance system: Individual insurance market is the solution
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss potential solutions to some of the problems in the health insurance industry, why he believes the individual insurance market is the solution for Americans, and more.
Oscar Health: The Most Undervalued Small Cap But With One Big Risk
I am bullish on Oscar Health (OSCR) due to its efficient D2C model, AI integration, and improving EBITDA margins despite high revenue growth. OSCR's opportunity in the ICHRA market is significant, with projections to increase 3x-5x by 2030, positioning it well against larger competitors. Risks include potential changes to ACA subsidies under future administrations, which could disrupt OSCR's current business model and force a shift to ICHRA.
Michael Burry's latest stock bet is skyrocketing
Michael Burry of ‘The Big Short' fame earned the admiration of investors all over the world by correctly predicting and profiting off of the 2008 subprime mortgage crisis.
Oscar Health, Inc. (OSCR) Q4 2024 Earnings Call Transcript
Oscar Health, Inc. (NYSE:OSCR ) Q4 2024 Earnings Conference Call February 4, 2025 5:00 PM ET Company Participants Chris Potochar – Vice President of Treasury and Investor Relations Mark Bertolini – Chief Executive Officer Scott Blackley – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Josh Raskin – Nephron Research Michael Ha – Baird Jonathan Yong – UBS Jessica Tassan – Piper Sandler Adam Ron – Bank of America Operator Good evening. My name is Rob, and I will be your conference operator today.
Oscar Health Reports First Profitable Year as Digital Mix Drives Engagement
The U.S. healthcare sector has undergone a rapid digital transformation in recent years, driven by a combination of regulatory shifts, consumer demand and technological advancements. The pandemic accelerated the adoption of telemedicine, remote monitoring and artificial intelligence (AI)-driven diagnostics, making digital health an essential component of modern care delivery.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Lags Revenue Estimates
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.66 per share a year ago.
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $16.28, indicating a -0.12% shift from the previous trading day.
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.65, marking a -1.57% move from the previous day.
Oscar Health: Trump Uncertainty Creates Buying Opportunity
Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 years. Despite not being profitable yet, Oscar Health is projected to achieve GAAP profitability in FY24, with EPS expected to grow to $0.51 by FY25. The key risk is the repeal of ACA by the Trump administration, which would significantly impact the affordability of health insurance premiums for individual buyers.
